A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
A combination of a diabetes drug and a PI3K inhibitor may have potential in preventing melanoma from spreading to the liver, according to a study from Columbia cancer researchers.
The CUIMC Healthy Aging Initiative will host its first Healthspan Extension Summit later this spring, highlighting the work of CUIMC researchers in basic, clinical, and population health sciences.
An inventor of new ways to manipulate molecules inside living cells to treat a wide range of conditions was inspired to become a scientist after reading the mysteries of Sherlock Holmes.
The Afternoon of Science series at the Vagelos College of Physicians and Surgeons continued Feb. 5 with presentations from Department of Biochemistry & Molecular Biophysics faculty.
A study led by Columbia and Cornell researchers finds, surprisingly, that anticoagulants do not prevent recurrent strokes in people with one type of heart condition.
A study from Columbia cancer researchers suggests drugs targeting the SMARCAL1 protein could strike a double blow against many cancers and make immunotherapy even more effective.
Public health researchers find that asthma is more common among U.S. individuals who reported cannabis use in the previous month, and the more frequent the use, the higher the likelihood of asthma.